Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer

ConclusionsWe first discovered that NDP concurrent IMRT for treating stage III/IV non-surgical elderly patients with NSCLC was good curative effect of better objective response rate and well-tolerated. However, within the low number of patients, only stage IV gained a survival benefit. (Source: Clinical and Translational Oncology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2upKEvb
via IFTTT